Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2005
12/06/2005CA2096528C Retroviral protease inhibitors
12/01/2005WO2005113605A1 Cross-linked antibodies
12/01/2005WO2005113558A2 Simple stereocontrolled synthesis of salinosporamide a
12/01/2005WO2005113534A2 Cxcr1 and cxcr2 chemokine antagonists
12/01/2005WO2005113525A1 N, n’-substituted-1,3-diamino-2-oxopropane derivatives, their pharmaceutical compositions and use
12/01/2005WO2005113503A2 Metabolites of (+)-(2s, 3s)-3-(2-methoxy-5-trifluoromethoxybenzylamino)-2-phenyl-piperidine
12/01/2005WO2005113498A1 Adrenergic receptor antagonists
12/01/2005WO2005113497A1 Substituted 5-aminomethyl-1h-pyrrol-2-carbxylic acid amides
12/01/2005WO2005113011A2 Prodrugs of ion channel modulating compounds and uses thereof
12/01/2005WO2005090301B1 Crystalline form of atorvastatin hemi calcium
12/01/2005WO2005082848A3 Method for preparing pyrrolidine oximes
12/01/2005WO2005077899A3 Amino-substituted tricyclic derivatives and methods of use
12/01/2005WO2005042516A3 Ligands of melanocortin receptors and compositions and methods related thereto
12/01/2005WO2004089894A8 Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
12/01/2005US20050267198 Novel processes for preparing amorphous atorvastatin hemi-calcium
12/01/2005US20050267169 Watersoluble prodrugs of propofol
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267126 Compounds derived from aryl carbamates, preparation thereof and uses of same
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
12/01/2005US20050267043 Novel inhibitors of hepatitis C virus NS3 protease
12/01/2005US20050266567 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
12/01/2005US20050265961 Biodegradable poly(beta-amino esters) and uses thereof
12/01/2005CA2566920A1 Metabolites of (+)-(2s, 3s)-3-(2-methoxy-5-trifluoromethoxybenzylamino)-2-phenyl-piperidine
12/01/2005CA2566892A1 Substituted 5-aminomethyl-1h-pyrrol-2-carbxylic acid amides
12/01/2005CA2565519A1 Cxcr1 and cxcr2 chemokine antagonists
12/01/2005CA2562701A1 Cross-linked antibodies
12/01/2005CA2561819A1 Prodrugs of ion channel modulating compounds and uses thereof
11/2005
11/30/2005EP1600437A1 Acid generators, sulfonic acids, sulfonyl halides, and radiation-sensitive resin compositions
11/30/2005EP1599445A1 Compounds having activity at 5ht2c receptor and uses thereof
11/30/2005EP1509500B1 Process for the preparation of the amorphous form of atorvastatin calcium salt
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP0963200B9 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
11/30/2005CN1703410A Isoquinoline compounds and medicinal use thereof
11/30/2005CN1703399A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
11/30/2005CN1703397A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229348C Method for preparing amlodipine
11/30/2005CN1229344C Farnesyl transferase inhibitors
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/30/2005CN1229100C Primary intermediates for oxidative coloration of hair
11/29/2005US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product
11/29/2005US6969744 Living and quasiliving cationic telechelic polymers quenched by N-substituted pyrrole and methods for their preparation
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
11/29/2005CA2194189C Process for producing cyclic lactames
11/24/2005WO2005111116A1 Biological molecule-reactive hydrophilic silicone surface
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110984A1 Process for producing cyclic n-hydroxyimide compound
11/24/2005WO2005087722A9 Diphenylmethyl compounds useful as muscarinic receptor antagonists
11/24/2005WO2004113297A9 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/24/2005US20050261504 Process for preparing intermediates
11/24/2005US20050261501 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
11/24/2005US20050261361 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
11/24/2005US20050261360 Dissolving the crystalline form in acetone, allowing to convert to amorphous form and then precipitating it out
11/24/2005US20050261359 Novel processes for preparing amorphous atorvastatin hemi-calcium
11/24/2005US20050261342 Metabolites of (+)-(2S,3S)-3(2-methoxy-5- trifluoromethoxybenzylamino)-2-phenyl-piperidine
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261290 Novel compounds of proline and morpholine derivatives
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261161 Stable crystals of pyrrole compound
11/24/2005US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
11/24/2005CA2567630A1 Biological molecule-reactive hydrophilic silicone surface
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/23/2005EP1598350A1 Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis
11/23/2005EP1598337A1 Method of obtaining an antiepileptic agent
11/23/2005EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
11/23/2005EP1597262A2 Substituted heterocycles
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005EP1597229A2 Pyrrolidine derivatives as oxytocin antagonists
11/23/2005EP1597228A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments
11/23/2005EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
11/23/2005EP1320522B1 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
11/23/2005EP0934263B1 Non-immunosuppressant fkbp rotamase inhibitors
11/23/2005CN1701059A Chemotherapeutic agents
11/23/2005CN1699545A Apparatus and method for controlling biofilms
11/23/2005CN1699349A Method and reagents for N-alkylating ureides
11/23/2005CN1228326C Method for producing N-alkenyl amides
11/23/2005CN1228325C Biguanide derivatives
11/22/2005US6967220 antibiotics; treating respiratory system disorders; n-hydroxy benzyl formamide derivatives
11/22/2005US6967199 Substituted diamine derivatives useful as motilin antagonists
11/22/2005US6967107 reacting with first one end and then the other of a polyoxyalkylene terminated on one end with a maleimidylarylaminocarbonyloxy group and on the other by a compound having a succinimidyloxycarbonyl group
11/22/2005CA2162122C Use of glycine-n,n-diacetic acid derivatives as biodegradable complexing agents for alkaline earth and heavy metal ions, and method of preparing them
11/17/2005WO2005109562A1 Material for electrolytic solution, ionic material-containing composition and use thereof
11/17/2005WO2005108594A1 Enzymatic ammonolysis process for the preparation of intermediates for dpp iv inhibitors
11/17/2005WO2005108393A1 Pyrrole or imidazole amides for treating obesity
11/17/2005WO2005108391A1 Amides as bace inhibitors
11/17/2005WO2005108384A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005108368A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/17/2005WO2005108361A1 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/17/2005WO2005108360A1 Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/17/2005WO2005108359A1 Novel compounds of proline and morpholine derivatives
11/17/2005WO2005108358A2 Pyrrolidine derivatives useful as bace inhibitors
11/17/2005WO2005108351A1 Benzonitrile derivatives to treat musculoskeletal frailty
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005085177A3 Biaryl amino acids and their use in dna binding oligomers
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 404